What should I know first?

Inhalant use disorder concerns repeated, difficult-to-control use of volatile substances for psychoactive effects, with significant harm or impairment. It does not mean every substance taken through the lungs: smoking tobacco or cannabis belongs to different diagnostic categories. Products and chemicals vary, and classification systems group some gases and other substances differently.

The actual exposure must therefore be identified rather than assumed from the word inhalant. A single poisoning can be extremely dangerous without establishing a chronic use disorder, and ordinary accidental or workplace exposure is a separate clinical question.

Symptoms and acute effects

Confusion, slurred speech, unsteadiness, nausea, blackouts or hallucinations can follow exposure. Anxiety and irritability may be reported during withdrawal after regular use. These signs are not specific to a use disorder and should not replace a medical examination.

Assessment

The clinician needs the product, likely chemicals, timing, repeated use, physical symptoms and the effect on everyday functioning. Acute poisoning and occupational or accidental exposure are distinct from addiction. Assessment should also explore developmental needs and the person's social circumstances.

How Common Is It?

Use is reported particularly among younger people, although it can affect adults as well. Reliable prevalence estimates depend on which chemicals are counted, how questions are phrased and whether a study measures experimentation, recent use or a disorder. These are different outcomes.

Cases of poisoning and emergency care also do not reveal the full prevalence of sustained harmful use. The limited attention given to some exposures can leave important gaps in knowledge. A low estimated frequency does not reduce the urgency of a potentially fatal episode.

What Causes It?

Availability, social circumstances, curiosity, distress and individual vulnerability can all contribute. Repeated use may become reinforced by its effects or by the setting in which it occurs, while difficult family or social circumstances can make support harder to obtain. These factors are not a diagnostic checklist and do not make any community inherently prone to addiction.

Some products are inexpensive or familiar, but accessibility is not evidence of safety. Care should explore the person's reasons for use, exposure risks and unmet needs without relying on stereotypes.

What Do We Know About the Brain?

Volatile chemicals can affect brain activity and coordination, and some can also injure the nervous system directly or reduce oxygen available to the brain. Different chemicals have different effects, so one simplified mechanism would be misleading. Repeated exposure can affect thinking and daily functioning, but an individual's symptoms require medical assessment rather than an automatic conclusion of permanent damage.

Brain imaging is not a routine test for a use disorder. When neurological injury is suspected, appropriate examination and investigation address that complication separately from the behavioural pattern of use.

Conditions With Similar Symptoms

Alcohol or sedative intoxication, neurological illness, head injury and other poisonings can resemble an inhalant exposure. Confusion may indicate delirium or oxygen deprivation and requires urgent assessment. Mood or attention changes can reflect an independent condition, a substance effect or both.

Occupational or accidental chemical injury should not be mislabelled as addiction. Conversely, absence of an obvious odour does not exclude exposure. Diagnosis relies on the history, physical findings and targeted investigation, while sudden breathing difficulty, seizures or collapse are treated as emergencies.

Other Conditions That Can Occur Together

Other substance use, depression, anxiety and developmental or social difficulties may coexist and deserve assessment. Medical complications can involve the heart, lungs, liver, kidneys, hearing or nervous system, depending on the substance and exposure. These possibilities are not inevitable outcomes for every person, but they guide examination and follow-up.

Young people may need coordination with family, school and safeguarding services according to their circumstances. A supportive approach should address safety and treatment access without turning suspected substance use into a presumption of misconduct.

Care and support

Acute toxicity is treated medically. For continuing problems, a GP or local drug service can help develop a plan, including practical and psychological support. The appropriate service for a young person may differ from an adult service; ask which local pathway covers their age and needs.

The role of medicines

This article does not identify a routine UK maintenance medicine for volatile-substance dependence. Treatment of poisoning, physical injury or an independently diagnosed condition is a separate clinical decision. An opioid-substitution regimen should not be copied into this article simply because both concern substance use.

What to Expect Over Time

Outcomes vary with the substance, severity and duration of exposure, complications and available support. Some symptoms may improve when exposure ends, while certain injuries can persist and require rehabilitation or other care. It is not possible to infer prognosis from one episode or one label.

Returning to use should prompt renewed safety assessment and adjustment of support rather than a declaration that recovery is impossible. Follow-up can track memory, movement, mood and daily functioning as well as progress in controlling the use pattern.

Family and environmental support

A calm conversation is more useful than assuming bad character. Discuss access to products, pressures and other difficulties while making the environment safer. Family or school support should respect the young person's needs and be coordinated with clinicians where health risks are present.

When to seek urgent help

Household availability does not mean safety: volatile substances can disrupt breathing and heart rhythm. Collapse, difficulty breathing, severe confusion or a suspected poisoning needs emergency help. Tell responders the product if known and avoid exposing yourself to fumes while trying to help.

History

Inhalant-related harm has often received less attention than better-known drug problems, despite the availability of volatile chemicals in everyday products. Older educational accounts sometimes placed these exposures in a brief miscellaneous category, which can obscure major differences between chemicals. Modern classifications distinguish harmful patterns of use, dependence, intoxication and induced conditions while still differing in how particular substances are grouped.

DSM-5's broader change from separate abuse and dependence labels also affected how use disorders are described. Contemporary care emphasizes identification of the actual exposure, medical complications and developmentally appropriate support. Historical descriptions should not be used to assume that familiar commercial products are safe or that all inhaled substances produce the same syndrome.

Sources and References

  1. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  2. Inhalants

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  3. Substance use — inhalants

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  4. What Is a Substance Use Disorder? (physician review 2024-04)

    Scope: International scientific background; not UK prescribing or healthcare guidance.

  5. Glues, gases and aerosols: effects and risks

    Scope: United Kingdom educational information.

  6. Drug addiction: getting help

    Scope: England service information.

  7. Advice for parents and carers

    Scope: United Kingdom educational information.

  8. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)

    Scope: International explanatory background; not UK prescribing or service guidance.

  9. Schizophrenia
  10. NIMH: Understanding psychosis

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top